Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 40201-40250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05806931
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
PHASE2Recruiting
50 participants
Started: May 17, 2023 · Completed: May 1, 2027
2 conditions1 sponsor9 locations
NCT05874739
Mobilise-D: Extension Study
N/ARecruiting
651 participants
Started: May 17, 2023 · Completed: Jul 28, 2025
2 conditions6 sponsors1 location
NCT05476991
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
PHASE3Recruiting
2,800 participants
Started: May 17, 2023 · Completed: Sep 1, 2027
8 conditions1 sponsor1 location
NCT05586581
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
PHASE1/PHASE2Recruiting
70 participants
Started: May 17, 2023 · Completed: Dec 31, 2030
4 conditions3 sponsors1 location
NCT06451211
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
PHASE2Recruiting
53 participants
Started: May 17, 2023 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT05879055
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
PHASE2Recruiting
60 participants
Started: May 17, 2023 · Completed: Jan 1, 2028
1 condition1 sponsor13 locations
NCT05883553
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
NARecruiting
40 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors2 locations
NCT05580861
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
PHASE1/PHASE2Recruiting
64 participants
Started: May 17, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05921578
Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.
NARecruiting
100 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05859412
Mechanisms of Neurodynamic Treatments
NARecruiting
108 participants
Started: May 17, 2023 · Completed: Apr 1, 2026
6 conditions2 sponsors1 location
NCT05791864
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy with TTX-381 for the Ocular Manifestations Associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease
PHASE1/PHASE2Recruiting
16 participants
Started: May 17, 2023 · Completed: Jul 30, 2030
1 condition1 sponsor1 location
NCT07021911
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
N/ARecruiting
300 participants
Started: May 17, 2023 · Completed: May 17, 2029
2 conditions1 sponsor1 location
NCT06758011
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
NARecruiting
2,395 participants
Started: May 17, 2023 · Completed: Nov 17, 2026
2 conditions1 sponsor1 location
NCT06763172
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
PHASE4Recruiting
12 participants
Started: May 17, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05658731
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
NARecruiting
338 participants
Started: May 17, 2023 · Completed: Dec 31, 2035
2 conditions3 sponsors2 locations
NCT05833438
Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
PHASE2Recruiting
45 participants
Started: May 17, 2023 · Completed: Jul 31, 2025
1 condition4 sponsors10 locations
NCT06584617
The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing
NARecruiting
66 participants
Started: May 17, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT05860400
Efficacy and Safety of Comprehensive Treatment in Patients with IR-CAD: a Self-controlled Cohort Study
N/ARecruiting
39 participants
Started: May 17, 2023 · Completed: Sep 30, 2025
7 conditions1 sponsor1 location
NCT05467306
Enhancing PrEP Outcomes Among Kenyan Adolescent Girls and Young Women With a Novel Pharmacy-based PrEP Delivery Platform
NARecruiting
1,900 participants
Started: May 17, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05575401
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NARecruiting
160 participants
Started: May 17, 2023 · Completed: Jan 31, 2026
7 conditions1 sponsor4 locations
NCT05996432
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
EARLY_PHASE1Recruiting
48 participants
Started: May 17, 2023 · Completed: May 31, 2029
2 conditions2 sponsors1 location
NCT05879133
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
NARecruiting
30 participants
Started: May 17, 2023 · Completed: Jul 3, 2027
1 condition2 sponsors1 location
NCT05440227
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PHASE2Recruiting
36 participants
Started: May 17, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06170840
A Study of QY101 Ointment in Subjects With Plaque Psoriasis
PHASE2Recruiting
160 participants
Started: May 17, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05062889
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
PHASE2Recruiting
477 participants
Started: May 17, 2023 · Completed: Dec 31, 2027
4 conditions4 sponsors28 locations
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
PHASE2Recruiting
100 participants
Started: May 17, 2023 · Completed: Nov 4, 2036
1 condition1 sponsor74 locations
NCT05444127
Oral Health and Wilson's Disease: SOMAWI
N/ARecruiting
150 participants
Started: May 17, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor3 locations
NCT05752981
Multi-channel Time-resolved Functional Near Infrared Spectroscopy for Prevention of Perioperative Brain Injury
N/ARecruiting
100 participants
Started: May 16, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05804084
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
PHASE2Recruiting
60 participants
Started: May 16, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT05875103
The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task
NARecruiting
302 participants
Started: May 16, 2023 · Completed: Nov 30, 2029
3 conditions1 sponsor1 location
NCT05875038
Superiority of Intelligent Video Surveillance + Telealarm Over Telealarm Alone in Elderly People at Risk of Falling
NARecruiting
395 participants
Started: May 16, 2023 · Completed: Dec 31, 2026
4 conditions12 sponsors1 location
NCT05895305
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis
EARLY_PHASE1Recruiting
45 participants
Started: May 16, 2023 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT05890287
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
NARecruiting
60 participants
Started: May 16, 2023 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT05889091
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment
NARecruiting
12 participants
Started: May 16, 2023 · Completed: May 16, 2026
1 condition1 sponsor1 location
NCT05844293
Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
PHASE1Recruiting
40 participants
Started: May 16, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor2 locations
NCT05336188
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
PHASE2Recruiting
255 participants
Started: May 16, 2023 · Completed: Sep 30, 2028
7 conditions1 sponsor1 location
NCT06341699
Study of the Steroid Hormone Milieu in Obese Patients
N/ARecruiting
180 participants
Started: May 16, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05690685
PMS Study of Silver I Alginate Non-Woven Dressing (Hydro-Alginate)
NARecruiting
60 participants
Started: May 16, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors2 locations
NCT05673928
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
PHASE2Recruiting
30 participants
Started: May 16, 2023 · Completed: Mar 1, 2029
2 conditions3 sponsors1 location
NCT05265299
Trial to Determine Effective Aspirin Dose in COPD
PHASE3Recruiting
48 participants
Started: May 16, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05799144
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer
PHASE2Recruiting
54 participants
Started: May 16, 2023 · Completed: Sep 30, 2028
2 conditions1 sponsor2 locations
NCT05319730
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
PHASE1/PHASE2Recruiting
230 participants
Started: May 16, 2023 · Completed: Apr 10, 2029
1 condition1 sponsor56 locations
NCT06699875
Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal
NARecruiting
40 participants
Started: May 16, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05628207
Evaluation of the SCALED (SCaling AcceptabLE cDs)
N/ARecruiting
15,000 participants
Started: May 16, 2023 · Completed: Nov 16, 2025
2 conditions2 sponsors1 location
NCT05740540
Implant for Walking After Stroke
NARecruiting
6 participants
Started: May 16, 2023 · Completed: Jun 30, 2027
3 conditions4 sponsors2 locations
NCT05721742
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
NARecruiting
76 participants
Started: May 16, 2023 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05588141
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
PHASE1/PHASE2Recruiting
96 participants
Started: May 16, 2023 · Completed: Aug 2, 2032
2 conditions1 sponsor1 location
NCT05751473
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
NARecruiting
410 participants
Started: May 16, 2023 · Completed: Aug 31, 2026
1 condition2 sponsors12 locations
NCT05882513
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
PHASE2Recruiting
30 participants
Started: May 16, 2023 · Completed: May 31, 2030
2 conditions1 sponsor1 location
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
PHASE3Recruiting
240 participants
Started: May 16, 2023 · Completed: Aug 15, 2031
2 conditions1 sponsor68 locations